相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Reinventing clinical trials: a review of innovative biomarker trial designs in cancer therapies
Ja-An Lin et al.
BRITISH MEDICAL BULLETIN (2015)
Missing steps in a staircase: a qualitative study of the perspectives of key stakeholders on the use of adaptive designs in confirmatory trials
Munyaradzi Dimairo et al.
TRIALS (2015)
Adaptive Clinical Trial Design
Shein-Chung Chow
ANNUAL REVIEW OF MEDICINE, VOL 65 (2014)
Methodology of clinical trials for rare diseases
Catrin Tudur Smith et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2014)
Adaptive designs for clinical trials assessing biomarker-guided treatment strategies
J. Wason et al.
BRITISH JOURNAL OF CANCER (2014)
Marker Sequential Test (MaST) design
Boris Freidlin et al.
CLINICAL TRIALS (2014)
Biomarker enrichment strategies: matching trial design to biomarker credentials
Boris Freidlin et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
A comparison of Bayesian adaptive randomization and multi-stage designs for multi-arm clinical trials
James M. S. Wason et al.
STATISTICS IN MEDICINE (2014)
Biomarker driven population enrichment for adaptive oncology trials with time to event endpoints
Cyrus Mehta et al.
STATISTICS IN MEDICINE (2014)
Precision Medicine Clinical Trials: Defining New Treatment Strategies
Brandy M. Heckman-Stoddard et al.
Seminars in Oncology Nursing (2014)
Adaptive enrichment designs for clinical trials
Noah Simon et al.
BIOSTATISTICS (2013)
Trial Designs for Personalizing Cancer Care: A Systematic Review and Classification
Parvin Tajik et al.
CLINICAL CANCER RESEARCH (2013)
Novel Strategies to Test Biological Hypotheses in Early Drug Development for Advanced Prostate Cancer
Roberta Ferraldeschi et al.
CLINICAL CHEMISTRY (2013)
Genomic Biomarkers for Personalized Medicine: Development and Validation in Clinical Studies
Shigeyuki Matsui
COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE (2013)
A review of phase II trial designs for initial marker validation
Sumithra J. Mandrekar et al.
CONTEMPORARY CLINICAL TRIALS (2013)
Group sequential designs for developing and testing biomarker-guided personalized therapies in comparative effectiveness research
Tze Leung Lai et al.
CONTEMPORARY CLINICAL TRIALS (2013)
Design of oncology clinical trials: A review
Revathi Ananthakrishnan et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2013)
Evaluating Many Treatments and Biomarkers in Oncology: A New Design
Richard Kaplan et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Phase III Clinical Trials That Integrate Treatment and Biomarker Evaluation
Boris Freidlin et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Statistical and Practical Considerations for Clinical Evaluation of Predictive Biomarkers
Mei-Yin C. Polley et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Biomarker-based adaptive trials for patients With glioblastoma-lessons from I-SPY 2
Brian M. Alexander et al.
NEURO-ONCOLOGY (2013)
Clinical trials for precision oncology using next-generation sequencing
Richard Simon et al.
PERSONALIZED MEDICINE (2013)
A generalized Dunnett test for multi-arm multi-stage clinical studies with treatment selection
D. Magirr et al.
BIOMETRIKA (2012)
Efficacy and tolerability of rizatriptan in pediatric migraineurs: Results from a randomized, double-blind, placebo-controlled trial using a novel adaptive enrichment design
Tony W. Ho et al.
CEPHALALGIA (2012)
A 2-Stage Phase II Design with Direct Assignment Option in Stage II for Initial Marker Validation
Ming-Wen An et al.
CLINICAL CANCER RESEARCH (2012)
Reports from the 2010 Clinical and Translational Cancer Research Think Tank Meeting: Design Strategies for Personalized Therapy Trials
Donald A. Berry et al.
CLINICAL CANCER RESEARCH (2012)
Clinical trial designs for testing biomarker-based personalized therapies
Tze Leung Lai et al.
CLINICAL TRIALS (2012)
Randomized Phase II Trial Designs With Biomarkers
Boris Freidlin et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Incorporating biomarkers into clinical trial designs: points to consider
Edward Bradley
NATURE BIOTECHNOLOGY (2012)
Adaptive clinical trials in oncology
Donald A. Berry
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
From drug discovery to biomarker-driven clinical trials in lymphoma
Anas Younes et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
Cancer biomarkers: selecting the right drug for the right patient
Gary J. Kelloff et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Predictive biomarkers in colorectal cancer: usage, validation, and design in clinical trials
Qian Shi et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2012)
Study Designs and Statistical Analyses for Biomarker Research
Masahiko Gosho et al.
SENSORS (2012)
Bayesian clinical trials in action
J. Jack Lee et al.
STATISTICS IN MEDICINE (2012)
A two-stage Bayesian design for co-development of new drugs and companion diagnostics
Stella Wanjugu Karuri et al.
STATISTICS IN MEDICINE (2012)
Current development in clinical trials: issues old and new
David L. DeMets
STATISTICS IN MEDICINE (2012)
Clinical trials for predictive medicine
Richard Simon
STATISTICS IN MEDICINE (2012)
Optimal design of multi-arm multi-stage trials
James M. S. Wason et al.
STATISTICS IN MEDICINE (2012)
Adaptive trial designs: a review of barriers and opportunities
John A. Kairalla et al.
TRIALS (2012)
The BATTLE to Personalize Lung Cancer Prevention through Reverse Migration
Kathryn A. Gold et al.
CANCER PREVENTION RESEARCH (2011)
Adaptive Clinical Trial Designs for Simultaneous Testing of Matched Diagnostics and Therapeutics
Howard I. Scher et al.
CLINICAL CANCER RESEARCH (2011)
Vasopressors and the search for the optimal trial design
Ritesh Maharaj
CONTEMPORARY CLINICAL TRIALS (2011)
An introduction to adaptive designs and adaptation in CNS trials
Vladimir Dragalin
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2011)
Adaptive design clinical trials and trial logistics models in CNS drug development
Sue-Jane Wang et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2011)
Integrating biomarkers in clinical trials
Marc Buyse et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2011)
Outcome-Adaptive Randomization: Is It Useful?
Edward L. Korn et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Implementing prognostic and predictive biomarkers in CRC clinical trials
Sandra Van Schaeybroeck et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Integrating predictive biomarkers and classifiers into oncology clinical development programmes
Robert A. Beckman et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
An adaptive seamless phase II/III design for oncology trials with subpopulation selection using correlated survival endpoints
Martin Jenkins et al.
PHARMACEUTICAL STATISTICS (2011)
Statistical Considerations for the Next Generation of Clinical Trials
Wenting Wu et al.
SEMINARS IN ONCOLOGY (2011)
Exploring the benefits of adaptive sequential designs in time-to-event endpoint settings
Sarah C. Emerson et al.
STATISTICS IN MEDICINE (2011)
Incorporation of Biomarker Assessment in Novel Clinical Trial Designs: Personalizing Brain Tumor Treatments
Evanthia Galanis et al.
CURRENT ONCOLOGY REPORTS (2011)
The Cross-Validated Adaptive Signature Design
Boris Freidlin et al.
CLINICAL CANCER RESEARCH (2010)
A threshold sample-enrichment approach in a clinical trial with heterogeneous subpopulations
Aiyi Liu et al.
CLINICAL TRIALS (2010)
A Bayesian adaptive design with biomarkers for targeted therapies
Jens C. Eickhoff et al.
CLINICAL TRIALS (2010)
Clinical trials for predictive medicine: new challenges and paradigms
Richard Simon
CLINICAL TRIALS (2010)
Predictive biomarker validation in practice: lessons from real trials
Sumithra J. Mandrekar et al.
CLINICAL TRIALS (2010)
The efficiency of clinical trial designs for predictive biomarker validation
K. Y. Young et al.
CLINICAL TRIALS (2010)
Bayesian adaptive randomization designs for targeted agent development
J. Jack Lee et al.
CLINICAL TRIALS (2010)
Biostatistic Tools in Pharmacogenomics - Advances, Challenges, Potential
Yasunori Sato et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Phase II clinical trials in oncology: are we hitting the target?
Mei-Kim Ang et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2010)
Adaptive design clinical trials: Methodology, challenges and prospect
Rajiv Mahajan et al.
INDIAN JOURNAL OF PHARMACOLOGY (2010)
Adaptive Methods: Telling The Rest of the Story
Scott S. Emerson et al.
JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2010)
Design, Operation, and Interpretation of Clinical Trials
B. L. Pihlstrom et al.
JOURNAL OF DENTAL RESEARCH (2010)
Methodological aspects of lung cancer clinical trials in the era of targeted agents
Massimo Di Maio et al.
LUNG CANCER (2010)
Genomic markers for decision making: what is preventing us from using markers?
Vicky M. Coyle et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Biomarkers and surrogate end points-the challenge of statistical validation
Marc Buyse et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Clinical trial designs for evaluating the medical utility of prognostic and predictive biomarkers in oncology
Richard Simon
PERSONALIZED MEDICINE (2010)
Biomarker-adaptive clinical trial designs
Boris Freidlin et al.
PHARMACOGENOMICS (2010)
Adaptive patient enrichment designs in therapeutic trials
Sue-Jane Wang et al.
BIOMETRICAL JOURNAL (2009)
Effective Incorporation of Biomarkers into Phase II Trials
Lisa M. McShane et al.
CLINICAL CANCER RESEARCH (2009)
I-SPY 2: An Adaptive Breast Cancer Trial Design in the Setting of Neoadjuvant Chemotherapy
A. D. Barker et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Clinical Trial Designs for Predictive Biomarker Validation: One Size Does Not Fit All
Sumithra J. Mandrekar et al.
JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2009)
Clinical Trial Designs for Predictive Biomarker Validation: Theoretical Considerations and Practical Challenges
Sumithra J. Mandrekar et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Confirmatory adaptive designs with Bayesian decision tools for a targeted therapy in oncology
Werner Brannath et al.
STATISTICS IN MEDICINE (2009)
How do multi-stage, multi-arm trials compare to the traditional two-arm parallel group design - a reanalysis of 4 trials
F. M-S Barthel et al.
TRIALS (2009)
Issues in applying multi-arm multi-stage methodology to a clinical trial in prostate cancer: the MRC STAMPEDE trial
Matthew R. Sydes et al.
TRIALS (2009)
Advances in Clinical Trial Designs for Predictive Biomarker Discovery and Validation
Richard Simon
CURRENT BREAST CANCER REPORTS (2009)
Group sequential and adaptive designs - A review of basic concepts and points of discussion
Marc Vandemeulebroecke
BIOMETRICAL JOURNAL (2008)
Statistical Issues in Translational Cancer Research
Stephen L. George
CLINICAL CANCER RESEARCH (2008)
The Use of Genomics in Clinical Trial Design
Richard Simon
CLINICAL CANCER RESEARCH (2008)
Randomized phase III clinical trial designs for targeted agents
Antje Hoering et al.
CLINICAL CANCER RESEARCH (2008)
Bayesian adaptive design for targeted therapy development in lung cancer - a step toward personalized medicine
Xian Zhou et al.
CLINICAL TRIALS (2008)
Development and validation of biomarker classifiers for treatment selection
Richard Simon
JOURNAL OF STATISTICAL PLANNING AND INFERENCE (2008)
Utility of Adaptive Strategy and Adaptive Design for Biomarker-facilitated Patient Selection in Pharmacogenomic or Pharmacogenetic Clinical Development Program
Sue-Jane Wang
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2008)
On Two-stage Seamless Adaptive Design in Clinical Trials
Shein-Chung Chow et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2008)
Speeding up the evaluation of new agents in cancer
Mahesh K. B. Parmar et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Adaptive design methods in clinical trials - a review
Shein-Chung Chow et al.
ORPHANET JOURNAL OF RARE DISEASES (2008)
Adaptive clinical trials - Progress and challenges
Christopher S. Coffey et al.
DRUGS IN R&D (2008)
Pharmacogenomic predictor discovery in phase II clinical trials for breast cancer
Lajos Pusztai et al.
CLINICAL CANCER RESEARCH (2007)
Biomarker as a classifier in pharmacogenomics clinical trials: a tribute to 30th anniversary of PSI
Sue-Jane Wang
PHARMACEUTICAL STATISTICS (2007)
Biomarkers and the design of clinical trials in cancer
Graeme A. M. Fraser et al.
BIOMARKERS IN MEDICINE (2007)
Towards validation of statistically reliable biomarkers
Marc Buyse
EJC SUPPLEMENTS (2007)
Biomarker-adaptive threshold design: A procedure for evaluating treatment with possible biomarker-defined subset effect
Wenyu Jiang et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Multiplicity and flexibility in clinical trials
Werner Brannath et al.
PHARMACEUTICAL STATISTICS (2007)
Approaches to evaluation of treatment effect in randomized clinical trials with genomic subset
Sue-Jane Wang et al.
PHARMACEUTICAL STATISTICS (2007)
Statistical considerations for testing multiple endpoints in group sequential or adaptive clinical trials
H. M. James Hung et al.
JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2007)
Adaptive seamless designs: Selection and prospective testing of hypotheses
Christopher Jennison et al.
JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2007)
Statistical analysis for two-stage seamless design with different study endpoints
Shein-Chung Chow et al.
JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2007)
An adaptive Simon Two-Stage Design for phase 2 studies of targeted therapies
Cheryl L. Jones et al.
CONTEMPORARY CLINICAL TRIALS (2007)
Adaptive designs in clinical drug development - An Executive Summary of the PhRMA Working Group
Paul Gallo et al.
JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2006)
Bayesian clinical trials
DA Berry
NATURE REVIEWS DRUG DISCOVERY (2006)
Adaptive signature design: An adaptive clinical trial design for generating and prospectively testing a gene expression signature for sensitive patients
B Freidlin et al.
CLINICAL CANCER RESEARCH (2005)
One- and two-stage designs for stratified phase II clinical trials
WB London et al.
STATISTICS IN MEDICINE (2005)
Clinical trial designs for predictive marker validation in cancer treatment trials
DJ Sargent et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Statistical consideration of adaptive methods in clinical development
SC Chow et al.
JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2005)
Clinical trials of newer regimens for treating ovarian cancer: the rationale for Gynecologic Oncology Group Protocol GOG 182-ICON5
LJ Copeland et al.
GYNECOLOGIC ONCOLOGY (2003)
Novel designs for multi-arm clinical trials with survival outcomes with an application in ovarian cancer
P Royston et al.
STATISTICS IN MEDICINE (2003)
Seamlessly expanding a randomized phase II trial to phase III
LYT Inoue et al.
BIOMETRICS (2002)
Trials within trials:: Confirmatory subgroup analyses in controlled clinical experiments
LA Moyé et al.
CONTROLLED CLINICAL TRIALS (2001)
分享论文
